| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |